Three Cases of Cytomegalovirus Infection Following Pancreatic Islet Transplantation

Transplantation Proceedings

Volumn 39, Issue 5, 2007, Pages 1599-1603

  Yakubovich, N ^a   Fung, M A ^a   Thompson, D M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

VALGANCICLOVIR;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; PROPHYLAXIS; SEROCONVERSION;

ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; GANCICLOVIR; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; ISLETS OF LANGERHANS TRANSPLANTATION; RECURRENCE;

EID: 34250167155     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.01.074     Document Type: Article

References (12)

1. Schnitzler M.A., Lowell J.A., Hardinger K.L., et al. The association of cytomegalovirus sero-pairing with outcomes and costs following cadaveric renal transplantation prior to the introduction of oral ganciclovir CMV prophylaxis. Am J Transplant 3 (2003) 445
2. Freeman R.B., Paya C., Pescovitz M.D., et al. Risk factors for cytomegalovirus viremia and disease developing after prophylaxis in high-risk solid-organ transplant recipients. Transplantation 78 (2004) 1765
3. Preiksaitis J.K., Brennan D.C., Fishman J., et al. Canadian society of transplantation consensus workshop on cytomegalovirus management in solid organ transplantation final report. Am J Transplant 5 (2005) 218
4. Mourad G., Rostaing L., Legendre C., et al. Sequential protocols using basiliximab versus antithymocyte globulins in renal-transplant patients receiving mycophenolate mofetil and steroids. Transplantation 78 (2004) 584
5. Lo A., Stratta R.J., Egidi M.F., et al. Patterns of cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone with ganciclovir prophylaxis. Transpl Infect Dis 3 (2001) 8
6. Opelz G., Dohler B., and Ruhenstroth A. Cytomegalovirus prophylaxis and graft outcome in solid organ transplantation: a collaborative transplant study report. Am J Transplant 4 (2004) 928
7. Hafiz M.M., Poggioli R., Caulfield A., et al. Cytomegalovirus prevalence and transmission after islet allograft transplant in patients with type 1 diabetes mellitus. Am J Transplant 4 (2004) 1697
8. Cure P., Pileggi A., Faradji R.N., et al. Cytomegalovirus infection in a recipient of solitary allogeneic islets. Am J Transplant 6 (2006) 1089
9. Ryan E.A., Paty B.W., Senior P.A., et al. Five-year follow-up after clinical islet transplantation. Diabetes 54 (2005) 2060
10. Ryan E.A., Lakey J.R.T., Paty B.W., et al. Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes 51 (2002) 2148
11. Paya C., Humar A., Dominguez E., et al. Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 4 (2004) 611
12. Ryan E.A., Lakey J.R.T., Rajotte R.V., et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 50 (2001) 710